# Training/Dissemination-Resource for Molecular Imaging Agents in Precision Medicine

> **NIH NIH P41** · UT SOUTHWESTERN MEDICAL CENTER · 2024 · $68,731

## Abstract

TRAINING AND DISSEMINATION SUMMARY
We consider the NCBIB to be primarily about dissemination of our technology. The most important kind of
dissemination is training that we can provide not only to individuals in the molecular imaging community, but also
to those involved in the allied health sciences and other areas of STEM. We have significantly enhanced both
the training and dissemination aspects of the NCBIB in this renewal application. In terms of training, we intend
to reach out more actively to students in the community, including those underrepresented in STEM. We will
leverage the fact that we have ties to several historically black colleges and universities in the area. A second
innovation in education and training is to link our NCBIB to two other imaging-centric NCBIBs, one at Washington
University and the other at Harvard/MGH, whereby we will not only share reagents but also speakers at our
webinars and symposia. We will co-sponsor more educational activities than in the past, having recently
established formal ties to programs at the annual meeting of the World Molecular Imaging Society. Dissemination
has been enhanced through closer ties to large pharma and equipment manufacturers, as well as through
founding our own start-up companies, one dedicated to molecular imaging and theranostic agents and the other
to developing artificial intelligence solutions to issues in molecular imaging and therapy. That latter company, an
outgrowth from the Informatics Core in the Division of Nuclear Medicine and Molecular Imaging at Johns Hopkins,
will help to produce software that can be downloaded from our website by interested parties. We have come to
recognize that by partnering with industry we can perform or be involved in the kinds of studies necessary to
advance a product to FDA approval, and its attendant widespread dissemination. Education in entrepreneurship
is another new aspect to this core. The aforementioned activities will occur in concert with the usual means of
dissemination, including publication in peer-reviewed journals, book chapters, invited lectures and other media.
Because we generate clinical agents, we will also provide materials, protocols and IND cross-references when
requested, and through material transfer agreements, if necessary. We have also learned the importance of one-
on-one training, with the leaders of this core contributing many hours in this fashion, not only for disseminating
our domain expertise but also as a recruitment tool to the NCBIB.

## Key facts

- **NIH application ID:** 10848987
- **Project number:** 2P41EB024495-06A1
- **Recipient organization:** UT SOUTHWESTERN MEDICAL CENTER
- **Principal Investigator:** Lilja Solnes
- **Activity code:** P41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $68,731
- **Award type:** 2
- **Project period:** 2017-09-15 → 2029-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10848987

## Citation

> US National Institutes of Health, RePORTER application 10848987, Training/Dissemination-Resource for Molecular Imaging Agents in Precision Medicine (2P41EB024495-06A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10848987. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*